Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The PML/RARα-Regulated MiR-181a/b-Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia

Daniela Braeuer-Hartmann, Jens-Uwe Hartmann, Dennis Gerloff, Christiane Katzerke, Alexander Arthur Wurm, Maria Vittoria Verga Falzacappa, Pier Guiseppe Pelicci, Carsten Müller-Tidow, MD, Daniel G. Tenen, MD, Dietger Niederwieser, MD, Gerhard Behre, MD

Blood (2014) 124 (21): 2195.

https://doi.org/10.1182/blood.V124.21.2195.2195

Published: 2014

Journal Articles

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

Ilaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, Enrico Derenzini, MD, Anna Ferrari, Cristina Papayannidis, Claudia Venturi, Annalisa Lonetti, Viviana Guadagnuolo, Federica Cattina, Emanuela Ottaviani, Maria Chiara Abbenante, Domenico Russo, Michele Baccarani, MD, Pier Giuseppe Pelicci, Giovanni Martinelli, MD

Blood (2012) 120 (21): 1496.

https://doi.org/10.1182/blood.V120.21.1496.1496

Published: 2012

Journal Articles

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2011) 118 (21): 76.

https://doi.org/10.1182/blood.V118.21.76.76

Published: 2011

Journal Articles

PML/RARα -Regulated MicroRNA 181b Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia

Daniela Braeuer-Hartmann, Jens-Uwe Hartmann, Dennis Gerloff, Christiane Katzerke, Maria Vittoria Verga Falzacappa, Pier Guiseppe Pellicci, Carsten Mueller-Tidow, MD, Daniel G. Tenen, MD, Dietger Niederwieser, MD, Gerhard Behre, MD

Blood (2011) 118 (21): 1361.

https://doi.org/10.1182/blood.V118.21.1361.1361

Published: 2011

Journal Articles

STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation

Maria Vittoria Verga Falzacappa, Maja Vujic Spasic, Regina Kessler, Jens Stolte, Matthias W. Hentze, Martina U. Muckenthaler

Blood (2006) 109 (1): 353–358.

https://doi.org/10.1182/blood-2006-07-033969

Published: 2006

NARROW

The PML/RARα-Regulated MiR-181a/b-Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

PML/RARα -Regulated MicroRNA 181b Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia

STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation

Email alerts

ASH Publications

American Society of Hematology

The PML/RARα-Regulated MiR-181a/b-Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

PML/RARα -Regulated MicroRNA 181b Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia

STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only